Latest mRNA Vaccine for RSV Wins Expedited Review
Past attempts to develop it have ended in tragedy, with two babies dying despite appearing to tolerate it at first.
STORY AT-A-GLANCE
Moderna just moved one step closer to bringing mRNA-1345, an RSV shot, to market
The U.S. Food and Drug Administration granted the experimental shot fast-track designation in August 2021
Now, Moderna’s mRNA RSV shot has been given Breakthrough Therapy Designation, which allows for faster development and an expedited review period
RSV is us…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.